← Leaderboards
Mauricio Henriques Pontes
Pennsylvania State Univ Hershey Med Ctr
$1,709,287
Attributed
$1,709,287
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $663.8K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,709,287 · 2
By mechanism
R01$1,273,907 · 1
R21$435,380 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Bacteria”
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Gary Fanger · Rise Therapeutics, Llc$19,697,313
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$14,299,891
Research focus
BacteriaMutantProteinsCell PhysiologyGenesBehaviorOrganismPathway InteractionsAffectCellsAnimalsCoculture TechniquesBenignBindingBacteriophagesAnabolismBacterial ProteinsCell TypeBacterial GenesAmino AcidsCelluloseChronic InfectionCell MotilityCell Density
Grant awards (4)
Genetics and physiology of the tsetse fly bacterial endosymbiont Sodalis glossinidius$610,143
R01 · FY2025 · AI · contact PI
Genetics and physiology of the tsetse fly bacterial endosymbiont Sodalis glossinidius$663,764
R01 · FY2024 · AI · contact PI
Metabolic control of the second messenger cyclic diguanylate: implications to intracellular bacterial pathogens$197,900
R21 · FY2021 · AI · contact PI
Metabolic control of the second messenger cyclic diguanylate: implications to intracellular bacterial pathogens$237,480
R21 · FY2020 · AI · contact PI